Screener
Cytek Biosciences, Inc. CTKB Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
FAQ
- What is Cytek Biosciences, Inc.'s invested capital?
- Cytek Biosciences, Inc. (CTKB) reported invested capital of $265.14M in Q2 2026.
- How has Cytek Biosciences, Inc.'s invested capital changed year-over-year?
- Cytek Biosciences, Inc.'s invested capital decreased by 17.2% year-over-year, from $320.32M to $265.14M.
- What is the long-term trend for Cytek Biosciences, Inc.'s invested capital?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s invested capital has grown at a 55.9% compound annual growth rate (CAGR), from $55.97M to $330.2M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Cytek Biosciences, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude